291 related articles for article (PubMed ID: 26503654)
1. Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication.
Merino-Ramos T; Vázquez-Calvo Á; Casas J; Sobrino F; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):307-15. PubMed ID: 26503654
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
[TBL] [Abstract][Full Text] [Related]
3. Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models.
Jiménez de Oya N; Esler WP; Huard K; El-Kattan AF; Karamanlidis G; Blázquez AB; Ramos-Ibeas P; Escribano-Romero E; Louloudes-Lázaro A; Casas J; Sobrino F; Hoehn K; James DE; Gutiérrez-Adán A; Saiz JC; Martín-Acebes MA
Emerg Microbes Infect; 2019; 8(1):624-636. PubMed ID: 30999821
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.
Blázquez AB; Vázquez-Calvo Á; Martín-Acebes MA; Saiz JC
Viruses; 2018 Feb; 10(2):. PubMed ID: 29473907
[TBL] [Abstract][Full Text] [Related]
5. The composition of West Nile virus lipid envelope unveils a role of sphingolipid metabolism in flavivirus biogenesis.
Martín-Acebes MA; Merino-Ramos T; Blázquez AB; Casas J; Escribano-Romero E; Sobrino F; Saiz JC
J Virol; 2014 Oct; 88(20):12041-54. PubMed ID: 25122799
[TBL] [Abstract][Full Text] [Related]
6. Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.
Jiménez de Oya N; Blázquez AB; Casas J; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712653
[TBL] [Abstract][Full Text] [Related]
7. Skin tropism during Usutu virus and West Nile virus infection: an amplifying and immunological role.
Vouillon A; Barthelemy J; Lebeau L; Nisole S; Savini G; Lévêque N; Simonin Y; Garcia M; Bodet C
J Virol; 2024 Jan; 98(1):e0183023. PubMed ID: 38088560
[TBL] [Abstract][Full Text] [Related]
8. West Nile virus replication requires fatty acid synthesis but is independent on phosphatidylinositol-4-phosphate lipids.
Martín-Acebes MA; Blázquez AB; Jiménez de Oya N; Escribano-Romero E; Saiz JC
PLoS One; 2011; 6(9):e24970. PubMed ID: 21949814
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
Nelson J; Roe K; Orillo B; Shi PY; Verma S
Antiviral Res; 2015 Oct; 122():39-45. PubMed ID: 26225754
[TBL] [Abstract][Full Text] [Related]
10. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection.
Jiménez de Oya N; San-Félix A; Casasampere M; Blázquez AB; Mingo-Casas P; Escribano-Romero E; Calvo-Pinilla E; Poderoso T; Casas J; Saiz JC; Pérez-Pérez MJ; Martín-Acebes MA
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0168722. PubMed ID: 36920206
[TBL] [Abstract][Full Text] [Related]
12. West Nile Virus-Inclusive Single-Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response within Single Cells.
O'Neal JT; Upadhyay AA; Wolabaugh A; Patel NB; Bosinger SE; Suthar MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626670
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening.
Zhang HL; Ye HQ; Deng CL; Liu SQ; Shi PY; Qin CF; Yuan ZM; Zhang B
Antiviral Res; 2017 May; 141():38-47. PubMed ID: 28202375
[TBL] [Abstract][Full Text] [Related]
14. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-
Eyer L; Fojtíková M; Nencka R; Rudolf I; Hubálek Z; Ruzek D
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642926
[TBL] [Abstract][Full Text] [Related]
15. The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection.
Pliego Zamora A; Edmonds JH; Reynolds MJ; Khromykh AA; Ralph SJ
Virology; 2016 Aug; 495():18-32. PubMed ID: 27152479
[TBL] [Abstract][Full Text] [Related]
16. Fatty acids are required for epidermal permeability barrier function.
Mao-Qiang M; Elias PM; Feingold KR
J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel small-molecule inhibitors of West Nile virus infection.
Noueiry AO; Olivo PD; Slomczynska U; Zhou Y; Buscher B; Geiss B; Engle M; Roth RM; Chung KM; Samuel M; Diamond MS
J Virol; 2007 Nov; 81(21):11992-2004. PubMed ID: 17715228
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid.
Halvorson DL; McCune SA
Lipids; 1984 Nov; 19(11):851-6. PubMed ID: 6549204
[TBL] [Abstract][Full Text] [Related]
19. Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus Replication.
Slonchak A; Shannon RP; Pali G; Khromykh AA
J Virol; 2015 Dec; 90(5):2388-402. PubMed ID: 26676784
[TBL] [Abstract][Full Text] [Related]
20. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells.
Michaelis M; Kleinschmidt MC; Doerr HW; Cinatl J
J Antimicrob Chemother; 2007 Nov; 60(5):981-6. PubMed ID: 17872917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
